Literature DB >> 7189463

Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS).

M Dardenne, J M Pléau, J F Bach.   

Abstract

Chromatography of normal human or mouse serum on Sephadex G-150 revealed the presence of two peaks of activity in the rosette assay used for the characterization of the serum thymic factor (FTS). One peak corresponded to the elution volume of FTS (mol. wt. 867), the other to molecules with mol. wts. of 40 000-60 000. Both peaks were absent in serum of thymectomized (Tx) mice but could be induced in such Tx mice by injection of synthetic FTS. Study of the biological half-life of both peaks (assessed by the rosette assay) and demonstration of their specific retention on anti-FTS immunosorbent indicate, altogether with direct binding experiments, that FTS is transported in serum by a molecule with a mol. wt. of the order of that of albumin or prealbumin. It is apparent that FTS bound to this molecule is responsible for the biological FTS-like activity associated with large mol. wt. fractions of normal serum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189463     DOI: 10.1002/eji.1830100203

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Common antigenicity between a human thymic epithelial cell product and a thymus-dependent serum factor.

Authors:  E F Potworowski; D Kowalczyk; V V Micusan; T Seemayer
Journal:  Experientia       Date:  1982-07-15

2.  The serum thymic factor (FTS). Chemical and biological aspects.

Authors:  J M Pleau; M Dardenne; J F Bach
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

3.  Differential serum protein binding of benzidine- and benzidine-congener based dyes and their derivatives.

Authors:  M Emmett; C E Cerniglia; A J Crowle
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

4.  Generation of a monoclonal antibody against facteur thymique serique (FTS).

Authors:  K Ohga; G S Incefy; C Y Wang; R A Good
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

5.  Lymphocyte chemotaxis in inflammation. IX. Further characterization of lymphocyte chemotactic lymphokines produced by purified protein derivative-stimulation in vitro and in vivo.

Authors:  S Harita; Y Shimokawa; Y Mibu; M Ishida; H Hayashi
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

6.  Impaired peripheral zinc metabolism in patients with senile dementia of probable Alzheimer's type as shown by low plasma concentrations of thymulin.

Authors:  F Licastro; L J Davis; E Mocchegiani; N Fabris
Journal:  Biol Trace Elem Res       Date:  1996-01       Impact factor: 3.738

7.  Circulating thymic hormone levels in severe combined immunodeficiency.

Authors:  T Iwata; G S Incefy; R A Good; S Cunningham-Rundles; M Dardenne; N Kapoor; D Kirkpatrick; R J O'Reilly
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.